Publications by authors named "Lene W Vestermark"

Claim this Profile
C
Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.
Halfdan Sorbye, Geir Olav Hjortland, Lene Weber Vestermark, Morten Ladekarl, Johanna Svensson

Br J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.
Halfdan Sorbye, Geir Olav Hjortland, Lene Weber Vestermark, Morten Ladekarl, Johanna Svensson

Br J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials.
Lone Gamrath, Tobias Bruun Pedersen, Martin Vad Møller, Lone Marie Volmer, Linda Holst-Christensen, Lene Weber Vestermark

Curr Oncol Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms.
Hege Elvebakken, Andreas Venizelos, Aurel Perren, Anne Couvelard, Inger Marie B Lothe, Lene W Vestermark

Br J Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms.
Siren Morken, Seppo W Langer, Anna Sundlöv, Lene Weber Vestermark, Morten Ladekarl

Br J Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms.
Andreas Venizelos, Halfdan Sorbye, Hege Elvebakken, Aurel Perren, Inger Marie B Lothe, Lene W Vestermark

Endocr Relat Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.
Hege Elvebakken, Aurel Perren, Jean-Yves Scoazec, Laura H Tang, Birgitte Federspiel, Lene W Vestermark

Neuroendocrinology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms.
Hans-Christian Pommergaard, Kirstine Nielsen, Halfdan Sorbye, Birgitte Federspiel, Elizaveta M Tabaksblat, Lene W Vestermark

J Neuroendocrinol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3).
Abir Salwa Ali, Malin Grönberg, Seppo W Langer, Morten Ladekarl, Geir Olav Hjortland, Lene Weber Vestermark

Med Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.
Abir Salwa Ali, Malin Grönberg, Birgitte Federspiel, Jean-Yves Scoazec, Geir Olav Hjortland, Lene Weber Vestermark

PLoS One· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S-1 in combination with docetaxel and oxaliplatin in patients with advanced gastro-esophageal adenocarcinoma: two parallel phase 1/2a studies.
Per Pfeiffer, Camilla Qvortrup, Merete Krogh, Katrine Schoennemann, Lene W Vestermark

Acta Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with S-1 in older Caucasian patients with metastatic colorectal cancer (mCRC): Findings from an observational chart review.
Stine Braendegaard Winther, Kanita Zubcevic, Camilla Qvortrup, Lene Weber Vestermark, Helle Anita Jensen

Acta Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study.
Sven-Petter Haugvik, Eva Tiensuu Janson, Pia Österlund, Seppo W Langer, Ragnhild Sørum Falk, Lene Weber Vestermark

Ann Surg Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial.
Lene W Vestermark, Helle A Jensen, Per Pfeiffer

Acta Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum.
Katrine R Schoennemann, Jon K Bjerregaard, Tine P Hansen, Karin De Stricker, Morten F Gjerstorff, Lene W Vestermark

Gastric Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer.
Maria Andersen, Katrine R Schønnemann, Mette Yilmaz, Helle A Jensen, Lene W Vestermark

Acta Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of thalidomide in patients with brain metastases from malignant melanoma.
Lene W Vestermark, Susanne Larsen, Birgit Lindeløv, Lars Bastholt

Acta Oncol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Lene W Vestermark, Anders Jacobsen, Camilla Qvortrup, Flemming Hansen, Claus Bisgaard

Acta Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chemotherapy to patients with metastatic carcinoma of the esophagus and gastro-esophageal junction. A survey of a Cochrane review].
Lene Weber Vestermark, Peter Sørensen, Per Pfeiffer

Ugeskr Laeger· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA.
Hanne Primdahl, Anni Linnet Nielsen, Susanne Larsen, Elo Andersen, Merete Ipsen, Lene Weber Vestermark

Acta Oncol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment of Danish cancer patients in Hammelburg. A retrospective study of 34 patients].
Lene W Vestermark, Nina Keldsen, Per Pfeiffer, Kristian Aabo

Ugeskr Laeger· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis